also called a Zepbound pen. The vial doses available are 2.5 milligrams (mg) and 5 mg, which is limited compared to the 6 Zepbound pen doses. Single-dose vials may be less convenient than an auto ...

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...

The company is now offering 7.5 mg and 10 mg vials, higher doses than it's offered since launching Zepbound vials in August. It’s also slashing the cost of 2 mg and 5 mg vials by $50 a month.

Eli Lilly launches 7.5 mg and 10 mg Zepbound vials for $499, also reducing prices for 2.5 mg and 5 mg vials. Self-pay patients can access Zepbound vials through LillyDirect, bypassing third-party ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...

Last August, Eli Lilly began selling the lowest doses of Zepbound — 2.5 mg and 5 mg — in vials rather than the standard auto-injector pen, cutting the price by about half. Now, it’s adding ...

People taking Zepbound, or interested in starting, will now have several vial options, including 2.5 mg, 5 mg, 7.5 mg and 10 mg doses. According to Eli Lilly, the company is: Lowering the price of the ...

INDIANAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Today Eli Lilly and Company (NYSE: LLY) announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available for $499 with the ...

Eli Lilly announced that it is expanding its offerings of its hit weight loss drug Zepbound on Tuesday, a few days after the Food and Drug Administration lifted a shortage on Novo Nordisk’s Wegovy and ...

Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new available vial doses.